A study of the effect of telephone follow-up by pharmacists on diabetic patients

Usefulness of telephone tracking after medication by pharmacists for patients with type 2 diabetes - Randomized controlled trial in which pharmacists follow phone calls for patients with type 2 diabetes

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038880

Enrollment

Registered

2020-01-05

Start date

2020-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

In addition to regular care, the pharmacist calls five times for a total of three months. Based on &quot

telephone follow contents&quot

. The contents are: (1) Confirmation of side effects such as hypoglycemia, (2) Response to sick days, (3) Confirmation of adherence from remaining drug status, (4) Confirmation of additional use of co

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes who have been taking 2 or more oral antidiabetic drugs for more than 3 months. The prescription time at the time of consent is 28 days or more. Men and women over the age of 18 when obtaining consent. Consent for study participation was obtained. Patients who meet all of the above.

Exclusion criteria

Exclusion criteria: Use of insulin injection, use of GLP-1 receptor agonist, home patient, dementia, diabetes completely cured during study period, hospitalized patient, drug management is third party, dialysis patient, lactating woman, alcohol / Drug addiction. Those who receive dietary guidance from a dietitian during the survey period. The above is excluded.

Design outcomes

Primary

Measure	Time frame
Compare the DTR QOL of the intervention group and control group after 3 months with the baseline	—

Secondary

Measure	Time frame
HbA1c Copmare mean increase or decrease values of intervention group and control group Compliance and adherence Compare the mean number of days prescribed for the intervention group and the control group divided by the interval between visits. Remaining drug remaining drug amount Compare the baseline and difference of the intervention group and control group after 3 months. The price is calculated at the price determined by the Ministry of Health Labor and Welfare. Side effects sick days Compare the percentage of all phone calls in the intervention group that found side effects and sick days. Number of written reports to doctors Compare the number of written submissions in the intervention and control groups the number of drug changes and dose changes. Reduced drug Compared the increase and decrease in the number of drugs in the diabetes prescription of the intervention group and the control group.	—

Measure

Time frame

HbA1c Copmare mean increase or decrease values of intervention group and control group Compliance and adherence Compare the mean number of days prescribed for the intervention group and the control group divided by the interval between visits. Remaining drug remaining drug amount Compare the baseline and difference of the intervention group and control group after 3 months. The price is calculated at the price determined by the Ministry of Health Labor and Welfare. Side effects sick days Compare the percentage of all phone calls in the intervention group that found side effects and sick days. Number of written reports to doctors Compare the number of written submissions in the intervention and control groups the number of drug changes and dose changes. Reduced drug Compared the increase and decrease in the number of drugs in the diabetes prescription of the intervention group and the control group.

—

Countries

Japan

Contacts

Public ContactHirose Takashi

Total Medical Service Co., Ltd. Sakura Pharmacy, Shingu Chuo Station

shinguchuoekimae@msnw.co.jp092-410-1194

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026